| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/18/2001 | CN1303937A Novel polypeptide-human tissue anion transport polypeptide 41 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303935A Human charcot-leyden crystal 6, its code sequence, preparation method and application |
| 07/18/2001 | CN1303929A Novel polypeptide-robosomal protein 18 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303926A Novel polypeptide-NADH-cytochrome B5 reductase 33 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303921A Continuous ferment process |
| 07/18/2001 | CN1303868A Preparation process of gene recomibination calcitonin or calcitonin analog |
| 07/18/2001 | CN1303863A Novel polypeptide-human transcriptional elongation factor IIS51 and polynucleotide for coding this polypeptide |
| 07/17/2001 | US6262248 Dna encoding an arabidopsis thaliana rps2 polypeptide in plant cells provides resistance to pathogens |
| 07/17/2001 | US6262247 Polycyclic aromatic hydrocarbon induced molecules |
| 07/17/2001 | US6262246 DNA encoding mammalian neuropeptides FF (NPFF) receptors and uses thereof |
| 07/17/2001 | US6262244 Genes coding for the extracellular part of four specific nkg2 (natural killer) transmembrane proteins; useful in treating infectious diseases and cancer |
| 07/17/2001 | US6262242 Tumor suppressor designated TS10Q23.3 |
| 07/17/2001 | US6262237 Contacting protocadherin-encoding polynucleotide sequence with antibody (monoclonal, polyclonal, chimeric or humanized) antagonizes homophilic binding; useful for intercellular adhesion |
| 07/17/2001 | US6262233 Tissue factor pathway inhibitor-3 |
| 07/17/2001 | US6262025 Their encoded protein products, as well as derivatives and analogs thereof. |
| 07/17/2001 | US6262024 Neuron regulatory factor for promoting neuron survival |
| 07/17/2001 | US6262016 Transferrin receptor genes |
| 07/17/2001 | US6261827 Recombinant filamentous fungal cell having regulatory sequences which control expression of heme biosynthetic enzyme or enzymes; industrial production |
| 07/17/2001 | US6261821 Amino acid sequence of protease-sensitive peptide; transgenic plants with disease resistance; biological pest control |
| 07/17/2001 | US6261820 Fibronolytically active polypeptide |
| 07/17/2001 | US6261817 Guaa |
| 07/17/2001 | US6261805 Sialyiation of N-linked glycoproteins in the baculovirus expression vector system |
| 07/17/2001 | US6261804 Selection of proteins using RNA-protein fusions |
| 07/17/2001 | US6261803 Process for preparing functional recombinant tissue factor |
| 07/17/2001 | US6261801 Nucleic acids encoding tumor necrosis factor receptor 5 |
| 07/17/2001 | US6261799 Expression cassettes encoding soluble, non-cleavable, chimeric HIV-1 GP160 variants, their methods of construction, and methods for the production of GP160 variants |
| 07/17/2001 | US6261791 Method for diagnosing cancer using specific PSCA antibodies |
| 07/17/2001 | US6261790 Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies |
| 07/17/2001 | US6261787 Bifunctional molecules for delivery of therapeutics |
| 07/17/2001 | US6261559 Inhalation device |
| 07/17/2001 | US6261558 Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 07/17/2001 | US6261550 Proteins with cores |
| 07/17/2001 | US6261548 Polypeptides for leukemia inhibitor factors with amino acid sequences |
| 07/17/2001 | US6261535 Images of tumors |
| 07/17/2001 | CA2151141C Mammalian receptors for interleukin-10 (il-10) |
| 07/17/2001 | CA2126182C Humanized antibodies reactive with gpiib/iiia |
| 07/17/2001 | CA2110519C Bovine herpesvirus type 1 deletion mutants, vaccines based thereon, diagnostic kits detection of bovine herpesvirus type 1 |
| 07/17/2001 | CA2055615C Monoclonal antibodies for inducing tolerance |
| 07/12/2001 | WO2001049870A1 Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast |
| 07/12/2001 | WO2001049839A2 Method for expressing gene and use thereof |
| 07/12/2001 | WO2001049830A2 Improved lysosomal enzymes and lysosomal enzyme activators |
| 07/12/2001 | WO2001049828A1 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof |
| 07/12/2001 | WO2001049745A1 Methods and compositions for determining the purity of chemically synthesized nucleic acids |
| 07/12/2001 | WO2001049742A1 Method for making insulin precursors and insulin precursor analogs |
| 07/12/2001 | WO2001049740A1 Novel fgf homolog zfgf12 |
| 07/12/2001 | WO2001049715A2 Methods and compositions for inhibiting neoplastic cell growth |
| 07/12/2001 | WO2001049713A2 Stabilizing peptides, polypeptides and antibodies which include them |
| 07/12/2001 | WO2001049711A2 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | WO2001049163A1 Pp14 fusion proteins and methods for making and using the same |
| 07/12/2001 | WO2001012665A3 Helical cytokine zalpha48 |
| 07/12/2001 | WO2001004281A3 Dna coding for beta-tubulin and use thereof |
| 07/12/2001 | WO2001004151A3 TUBERCULOSIS VACCINE AND DIAGNOSTICS BASED ON THE MYCOBACTERIUM TUBERCULOSIS esat-6 GENE FAMILY |
| 07/12/2001 | WO2001002588A3 Generation of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests |
| 07/12/2001 | WO2000075278A9 Gene encoding nade, p75ntr-associated cell death executor and uses thereof |
| 07/12/2001 | WO2000065070A3 Cell culture process for glycoproteins |
| 07/12/2001 | WO2000063361A3 A multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides |
| 07/12/2001 | WO2000034447A8 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 07/12/2001 | WO2000000510A3 Growth factor modulators |
| 07/12/2001 | WO1999052541A3 Artery- and vein-specific proteins and uses therefor |
| 07/12/2001 | US20010007767 Genetic engineering |
| 07/12/2001 | US20010007755 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases |
| 07/12/2001 | US20010007752 Genetic engineering; nucleic acids |
| 07/12/2001 | DE19960500A1 Antikörper und Verfahren zu ihrer Herstellung, deren Verwendung sowie Immunisierungscocktails, Immunoassay-Sets und Peptide Antibodies and methods for their preparation, their use and immunization cocktails, immunoassay kits and peptides |
| 07/12/2001 | DE10064713A1 Preparation of gamma-poly(glutamic acid) using Bacillus species, useful e.g. in foods or cosmetics, includes pH adjustment, centrifuging, concentration and alcohol precipitation |
| 07/12/2001 | CA2402131A1 Methods and compositions for determining the purity of chemically synthesized nucleic acids |
| 07/12/2001 | CA2396401A1 Novel fgf homolog zfgf12 |
| 07/12/2001 | CA2395876A1 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | CA2395198A1 Pp14 fusion proteins and methods for making and using the same |
| 07/12/2001 | CA2395041A1 Stabilizing peptides, polypeptides and antibodies which include them |
| 07/12/2001 | CA2392844A1 Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast |
| 07/11/2001 | EP1114865A1 Production of human parathyroid hormone |
| 07/11/2001 | EP1114864A2 Mammalian cell surface antigens, related reagents |
| 07/11/2001 | EP1114863A2 Heregulins (HRGs), binding proteins of P185erb2 |
| 07/11/2001 | EP1114862A2 Use of polyeptides or their encoding nucleic acids for the diagnosis or treatment of skin diseases and their use in indentifying pharmacologically acitve substances |
| 07/11/2001 | EP1114830A1 Cerebral organic anion transporter and its gene |
| 07/11/2001 | EP1114827A1 Novel nucleic acid base pair |
| 07/11/2001 | EP1114166A1 Method for down-regulating osteoprotegerin ligand activity |
| 07/11/2001 | EP1114160A1 Moraxella catarrhalis basb034 polypeptides and uses thereof |
| 07/11/2001 | EP1114158A2 Human cytoskeleton associated proteins |
| 07/11/2001 | EP1114155A2 Human gpcr proteins |
| 07/11/2001 | EP1114152A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/11/2001 | EP1114145A1 Topa |
| 07/11/2001 | EP1114143A1 Streptococcal c beta protein compositions |
| 07/11/2001 | EP1114063A2 A method of producing a functional immunoglobulin superfamily protein |
| 07/11/2001 | EP1114062A1 MODIFIED $i(E. COLI) ENTEROTOXIN II SIGNAL PEPTIDE AND A MICROORGANISM EXPRESSING A FUSION PROTEIN OF SAID PEPTIDE AND A HETEROLOGOUS PROTEIN |
| 07/11/2001 | EP1114058A1 Polynucleotide and polypeptide sequences encoding rat mdr1a and screening methods thereof |
| 07/11/2001 | EP1113817A1 Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies |
| 07/11/2001 | EP0735819B1 Cryptophycins |
| 07/11/2001 | EP0600018B1 Hepatitis c assay utilizing recombinant antigens to c-100 region |
| 07/11/2001 | EP0593516B1 Methods of treatment of motor neuron diseases using members of the bdnf/nt-3/ngf family of molecules |
| 07/11/2001 | EP0495064B1 Birch pollen allergen p14 for diagnosis and therapy of allergic diseases |
| 07/11/2001 | CN1303440A Expression system for producing proteins |
| 07/11/2001 | CN1303439A Novel constructs for controlled expression of recombinant proteins in prokaryotic cells |
| 07/11/2001 | CN1303435A TAO protein kinases and methods of use therefor |
| 07/11/2001 | CN1303432A Novel insecticidal toxins from i(xenorhabdus nematophilus) and nucleic acid sequences coding therefor |
| 07/11/2001 | CN1303431A Humanized antibody against human tissue factor (TF) and process for constructing humanized antibody |
| 07/11/2001 | CN1303430A FAP alpha specific antibody with improved producibility |
| 07/11/2001 | CN1303429A Therapeutic applications of mature FLINT (mFLINT) polypeptides or OPG3, member of TNF receptor superfamily |
| 07/11/2001 | CN1303300A Isolated peptides corresponding to amino acid sequences of NY-ESO-1, wherein bind to MHC class I and MHC class II molecules, and uses thereof |
| 07/11/2001 | CN1302889A Polypeptide-human protein 70 containing plasmolemma regulation function and polynucleotide for coding it |